Sam, Mofaisa .

HRN: 19-40-14  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/26/2023
CEFTRIAXONE 1G (VIAL)
02/26/2023
03/05/2023
IVTT
1.2g
Q24
Typhoid Fever
Waiting Final Action 
02/26/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/26/2023
03/05/2023
IVTT
115mg
Q8
T/Ccintestinal Ileus; R/0 Obstruction
Waiting Final Action 
03/02/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/02/2023
03/08/2023
IV
165mg
OD
Sepsis Prob Sec To Typhoid Fever; SAM
Waiting Final Action 
03/02/2023
FLUCONAZOLE 150MG (CAP)
03/02/2023
03/08/2023
PO
65mg/pptab
OD
Sepsis Prob Sec To Typhoid Fever; SAM
Waiting Final Action 
03/02/2023
FLUCONAZOLE 150MG (CAP)
03/02/2023
03/02/2023
PO
132mg/pptab
OD
Sepsis Prob Sec To Typhoid Fever; SAM
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: